Cytek Biosciences, Inc. CTKB Accrued excise taxes for share repurchase
Accrued excise taxes for share repurchase at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept ctkb:AccruedExerciseTaxesForShareRepurchase.
The official record: Cytek Biosciences, Inc.’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s accrued excise taxes for share repurchase.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s accrued excise taxes for share repurchase?
- Cytek Biosciences, Inc. (CTKB) reported accrued excise taxes for share repurchase of $0 in Q4 2025.
- What does accrued excise taxes for share repurchase mean?
- Tracks the accrual of excise taxes specifically related to the company's share repurchase programs. It provides transparency into the tax-related costs associated with returning capital to shareholders through buybacks.